Article Text

Download PDFPDF
Revised advice on switching between antiepileptic products

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Medicines and Healthcare products Regulatory Agency (MHRA) has revisited advice it issued in 2013 on switching between oral antiepileptic drugs from different manufacturers.1 The new advice, published in the MHRA's Drug Safety Update, follows a review by the Commission of Human Medicines in 2016, which was prompted by feedback and requests for clarification on the 2013 advice from patients and healthcare professionals.

The core advice from 2013 has been updated with some refinements and revisions.1,2 For example, …

View Full Text